Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 70

1.

The multiple roles of Fas ligand in the pathogenesis of infectious diseases.

Dockrell DH.

Clin Microbiol Infect. 2003 Aug;9(8):766-79. Review.

2.

Activation-induced cell death: the controversial role of Fas and Fas ligand in immune privilege and tumour counterattack.

Maher S, Toomey D, Condron C, Bouchier-Hayes D.

Immunol Cell Biol. 2002 Apr;80(2):131-7. Review.

PMID:
11940113
3.

Fas-mediated apoptosis in tumor formation and defense.

Hug H.

Biol Chem. 1997 Dec;378(12):1405-12. Review.

PMID:
9461339
4.

Role of FAS in HIV infection.

Dianzani U, Bensi T, Savarino A, Sametti S, Indelicato M, Mesturini R, Chiocchetti A.

Curr HIV Res. 2003 Oct;1(4):405-17. Review.

PMID:
15049427
5.

The Fas signalling pathway and its role in the pathogenesis of cancer.

Houston A, O'Connell J.

Curr Opin Pharmacol. 2004 Aug;4(4):321-6. Review.

PMID:
15251123
6.

Fas and Fas ligand interactions in malignant disease.

Owen-Schaub L, Chan H, Cusack JC, Roth J, Hill LL.

Int J Oncol. 2000 Jul;17(1):5-12. Review.

PMID:
10853011
7.

The Fas system in the seminiferous epithelium and its possible extra-testicular role.

Riccioli A, Salvati L, D'Alessio A, Starace D, Giampietri C, De Cesaris P, Filippini A, Ziparo E.

Andrologia. 2003 Feb;35(1):64-70. Review.

PMID:
12558530
8.

New kids in the block: the role of FasL and Fas in kidney damage.

Ortiz A, Lorz C, Egido J.

J Nephrol. 1999 May-Jun;12(3):150-8. Review.

PMID:
10440512
9.

Fas/FasL interaction: a novel immune therapy approach with immobilized biologicals.

Scholz M, Cinatl J.

Med Res Rev. 2005 May;25(3):331-42. Review.

PMID:
15599929
10.

Induction of tolerance using Fas ligand: a double-edged immunomodulator.

Askenasy N, Yolcu ES, Yaniv I, Shirwan H.

Blood. 2005 Feb 15;105(4):1396-404. Epub 2004 Oct 14. Review.

11.

Storage, expression and function of Fas ligand, the key death factor of immune cells.

Lettau M, Paulsen M, Kabelitz D, Janssen O.

Curr Med Chem. 2008;15(17):1684-96. Review.

PMID:
18673218
12.

The role of Fas and FasL as mediators of anticancer chemotherapy.

Poulaki V, Mitsiades CS, Mitsiades N.

Drug Resist Updat. 2001 Aug;4(4):233-42. Review.

PMID:
11991678
13.

Fas and FasL in the homeostatic regulation of immune responses.

Lynch DH, Ramsdell F, Alderson MR.

Immunol Today. 1995 Dec;16(12):569-74. Review.

PMID:
8579749
14.

The central role of Fas-ligand cell signaling in inflammatory lung diseases.

Dosreis GA, Borges VM, Zin WA.

J Cell Mol Med. 2004 Jul-Sep;8(3):285-93. Review.

15.

The CD95(APO-1/Fas)/CD95L system.

Krammer PH.

Toxicol Lett. 1998 Dec 28;102-103:131-7. Review.

PMID:
10022244
16.

Involvement of Fas/FasL system in the pathogenesis of autoimmune diseases and Wilson's disease.

Stassi G, Di Felice V, Todaro M, Cappello F, Zummo G, Farina F, Trucco M, De Maria R.

Arch Immunol Ther Exp (Warsz). 1999;47(3):129-33. Review.

PMID:
10470438
17.

[FasL-Fas/APO-1 (CD95) system].

Sun CK, Ju G.

Sheng Li Ke Xue Jin Zhan. 1997 Apr;28(2):136-8. Review. Chinese. No abstract available.

PMID:
11038707
19.

[Membrane protein Fas/FasL system in viral infections].

Ma BJ, Hang CS.

Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi. 2001 Mar;15(1):94-7. Review. Chinese. No abstract available.

PMID:
12526314
20.

Regulation of apoptosis through CD95 (APO-I/Fas) receptor-ligand interaction.

Debatin KM, Beltinger C, Böhler T, Fellenberg J, Friesen C, Fulda S, Herr I, Los M, Scheuerpflug C, Sieverts H, Stahnke K.

Biochem Soc Trans. 1997 May;25(2):405-10. Review. No abstract available.

PMID:
9191126

Supplemental Content

Support Center